Latest news
3 Medical Stocks Standing Out After Crushing Q2 Earnings Expectations - TradingViewTradingView · Wed, 05 Aug 2026 23:10:00 GMTACADIA Pharmaceuticals Inc. Revenue Breakdown – BMV:ACAD - TradingViewTradingView · Wed, 05 Aug 2026 17:48:27 GMTACADIA Pharmaceuticals Inc. Stock 12‑Month Price Target Raised to $33.25, Implies 22% Upside - TradingViewTradingView · Wed, 05 Aug 2026 17:20:05 GMTACAD: Q2 revenue rose 17% to $308M, led by DAYBUE STIX growth and raised 2026 guidance - TradingViewTradingView · Tue, 04 Aug 2026 22:51:36 GMTACADIA Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Tue, 04 Aug 2026 22:03:55 GMTACADIA Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 21:37:35 GMTACADIA Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:ACAD - TradingViewTradingView · Mon, 27 Jul 2026 17:23:07 GMT4 Medical Stocks With the Right Setup for Q2 Earnings Beats - TradingViewTradingView · Mon, 27 Jul 2026 16:03:00 GMT